StockNews.com Begins Coverage on Arcadia Biosciences (NASDAQ:RKDA)

Equities research analysts at StockNews.com initiated coverage on shares of Arcadia Biosciences (NASDAQ:RKDA) in a note issued to investors on Friday. The brokerage set a “sell” rating on the basic materials company’s stock.

Separately, HC Wainwright reiterated a “buy” rating and set a $6.00 price target on shares of Arcadia Biosciences in a report on Wednesday, August 21st.

Arcadia Biosciences Trading Down 24.9 %

NASDAQ:RKDA opened at $2.90 on Friday. The firm has a fifty day simple moving average of $3.34 and a two-hundred day simple moving average of $3.02. The stock has a market capitalization of $3.94 million, a price-to-earnings ratio of -0.68 and a beta of 1.27. Arcadia Biosciences has a 12 month low of $1.85 and a 12 month high of $5.34.

About Arcadia Biosciences

Arcadia Biosciences, Inc produces and markets plant-based food and beverage products in the United States. The company develops crop improvements primarily in wheat to enhance farm economics by improving the performance of crops in the field, as well as their value as food ingredients. Its food, beverage, and body case products include GoodWheat, Zola coconut water, ProVault topical pain relief, and SoulSpring.